Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Michael Cho
Iowa State University, Department: Veterinary Sciences
Should you be removed from our database? Contact us at [email protected]. Read more below.
NeoVaxSyn Incorporated
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
NA
Induction of broadly neutralizing antibodies against CD4 binding site
PROJECT NARRATIVE Antibodies that can block (or neutralize) HIV-1 infection are important components of the body's immune system. The critical roadblock to AIDS vaccine development is the difficulty in eliciting neutralizing antibodies that are broadly reactive against many different variants of the virus. It is believed that preventing a critical step of virus binding to its cellular receptor molecule (CD4) is the best strategy to develop an AIDS vaccine. However, this has been a significant scientific challenge during the past three decades. The major goal of this proposal is to evaluate an innovative vaccine strategy that can train the body's immune system to produce antibodies that can block attachment of the virus to cells. Thus, successful completion of proposed studies will overcome a critical roadblock to AIDS vaccine development.
Filed on June 01, 2018.
Tell us what you know about Michael Cho's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Michael Cho filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Michael W. Cho | Iowa State University | Conflict of Interest | NeoVaxSyn Incorporated | Value cannot be readily determined |
| Michael Cho | Iowa State University | Conflict of Interest | NeoVaxSyn Incorporated | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.